A federal court in Texas has bolstered Novo Nordisk’s efforts to limit the production and sale of compounded versions of its GLP-1 drugs, Wegovy and Ozempic. Here are five notes: ...

Drugs that bind to and activate the receptors for the hormones GLP-1 and GIP are effective in the treatment of obesity and diabetes. Surprisingly, active substances are currently being developed that ...

With GLP-1 shortage officially over, patients who relied on compounded copies have only bad options to choose from ...

A judge denied compounders' request to keep making off-brand Wegovy and Ozempic after the FDA removed semaglutide from its shortage list.

The benefit of GLP-1 therapy couldn’t be explained by weight loss, suggesting that some pleiotropic effects may be at work.

Weight-loss drugs can be life-changing for people who have struggled to lose weight, however, some people who take them experience unpleasant and concerning side effects. In 2024, roughly 5 per ...

Treatment with glucagon-like peptide-1 receptor agonists (GLP-1RAs) may reduce the risk of dementia or cognitive impairment, according to findings from a study published in JAMA Neurology. This may be ...

NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) today announced the decision to discontinue development of danuglipron (PF-06882961), an oral glucagon-like peptide-1 (GLP-1) receptor agonist ...

33,950 people played the daily Crossword recently. Can you solve it faster than others?33,950 people played the daily Crossword recently. Can you solve it faster than others?

The In­sti­tute for Clin­i­cal and Eco­nom­ic Re­view, the non­prof­it drug pric­ing watch­dog, re­leased a new re­port on Wednes­day out­lin­ing po­ten­tial fed­er­al pol­i ...

GLP-1 medication use spiked, as well. Among adults with the highest category of obesity, about 4% used GLP-1 medications ... got a weekly shot of semaglutide, the drug in Ozempic and Wegovy ...